SK Hynix Says No Decision Yet on Reported Plan to List Treasury Shares as ADRs in the U.S.

COMPANY / Reporter Paul Lee / 2025-12-10 08:54:16

Photo courtesy of Yonhap News

 

[Alpha Biz= Paul Lee] SEOUL, Dec. 10 — SK Hynix said on Tuesday that while it is reviewing various options to enhance corporate value, no decision has been made regarding media reports that it is pursuing a U.S. listing of its treasury shares through American Depositary Receipts (ADRs).

The company made the statement in a regulatory filing before market open.

The Korea Economic Daily reported on Dec. 9 that SK Hynix is exploring a plan to list 2.4% of its treasury shares (17,407,808 shares) as ADRs on a U.S. exchange. The report said the company has received multiple proposals from global investment banks.

A U.S. listing could attract inflows from passive funds such as ETFs, as well as long-only funds that invest exclusively in U.S. markets. Industry observers note that Taiwan’s TSMC similarly gained a significant valuation boost after listing its ADR in the U.S. market in 1997.

Depositary receipts (DRs) are securities issued to facilitate trading of shares in overseas markets; when issued in the United States, they are referred to as ADRs.

Analysts say a U.S. ADR listing could help SK Hynix achieve a valuation closer to that of Micron, its key competitor. Currently, SK Hynix trades at an estimated forward price-to-earnings ratio (PER) of around 11x, far below Micron’s ~29x, indicating that the Korean chipmaker remains relatively undervalued.

 

 

 

Alphabiz Reporter Paul Lee(hoondork1977@alphabiz.co.kr)

주요기사

Celltrion Cancels Treasury Shares Worth KRW 1.7 Trillion in Record Shareholder Return Move
Samchundang Pharm Launches Legal Action Over Alleged False Reports Amid Share Price Plunge
KG Group to Acquire K Car for KRW 550 Billion, Building Integrated Mobility Ecosystem
Uber Explores Acquisition of Control Stake in Kakao Mobility
Mirae Asset Securities vs. Shinhan Investment Corp: Second Trial Over Lime Fund Dispute to Begin May 27
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

SNS